In the shadow of President Trump's efforts to lower drug prices, the Medicare drug price negotiation process that began in ...

Amgen Q1 2025 results beat estimates with strong product growth. Stay updated on tariff risks and drug pricing impacts.

The prices charged at the US launch of targeted cancer therapies have increased well above the rate of inflation every year since 2012.

Our Drug Pricing and Market Access team tracks recent developments in healthcare reform, the Medicaid Drug Rebate Program, the 340B Program, ...

The percentage of adults prescribed a GLP-1 drug like Wegovy or Zepbound jumped almost sevenfold over the past five years, ...

The percentage of overweight or obese adults prescribed GLP-1s jumped by almost 587% between 2019 and 2024, according to a ...

Healthcare has been running neck and neck with energy and consumer discretionary for the worst sector of 2025.

Cigna has announced a deal to cap client copays on popular GLP-1 weight loss drugs by Eli Lilly and Novo Nordisk at $200 per ...

Cigna’s pharmacy benefits unit Evernorth said the deal will bring prices down for employers and their workers.

Cigna Group ... weight-loss drugs that it says will make the medicines available to more patients. Under the new option, patients would pay less than the cash price for Eli Lilly & Co.’s ...

The new deal will also include a simplified pre-authorization process for the drugs, and patients will be able to access the drugs for the same price across ... While Cigna would not discuss ...